91.   When a new drug is marketed, side effects are virtually inevitable, and they are sometimes more severe or more common than when the drug was being tested.

92.   West Chester, Pennsylvania-based Cephalon developed Myotrophin with financial support from Emeryville, California-based Chiron, which plans to market the drug.

93.   Without FDA approval, the drug cannot be marketed in the U.S.

94.   Yet calcium channel blocker drugs have been marketed for two decades.

95.   Allergan is also currently seeking FDA clearance to market the drug to treat tension headaches and migraines.

96.   Approval by the panel, the European Committee for Proprietary Medicinal Products, is a key step in gaining permission to market the drug.

97.   Barker also lifted an injunction that prevented Pomona, N.Y.-based Barr from marketing the drug.

98.   Biochem Pharma, based in Montreal, Canada, is marketing the drug with Glaxo in North America.

99.   Columbus, Ohio-based Roxane Laboratories markets the drug under the name Viramune.

100.   DuPont will spin off its pharmaceutical division, which markets well-known drugs such as the AIDS treatment Sustiva, the company announced today.